An FDA-approved synthetic THC significantly reduces agitation in Alzheimer's patients, improving treatment outcomes and ...

An FDA-approved synthetic version of THC (the main ingredient in cannabis) reduces agitation in patients with Alzheimer's ...

A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.

A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.

In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show ...

Though agitation is a symptom of sundowning, this treatment approach didn't directly address sundowning ... Instead, it's a group of symptoms and behaviors that people with dementia may experience ...

Agitation is one of the most distressing symptoms of Alzheimer's dementia, and we are pleased to make positive strides forward in treatment of these patients." Paul Rosenberg, M.D., professor of ...